Tuesday, April 7, 2015

Pittsburgh Actos Bladder Cancer Lawsuits May Soon Settle

Actos bladder cancer lawsuit settlement.

As a Pittsburgh lawyer actively handling Actos bladder cancer lawsuits I am optimistic that my clients' cases may soon settle for money compensation.  Takeda, the maker of Actos, has offered $2.2 Billion for settlement of all current Actos bladder cancer lawsuits including Pittsburgh Actos lawsuits as reported by Bloomberg here.  If this Actos bladder cancer lawsuit settlement were accepted, it would result settlements for Pittsburgh patients with bladder cancer after taking diabetes drug Actos in the range of $275,000 per patient.

Actos (pioglitazone) is a member of a controversial class of drugs known as thiazolidinediones, which have been linked to serious cardiovascular injuries. Since 2007, Actos has been one of the most popular drugs in Pittsburgh, Pennsylvania for treating Type 2 diabetes.  Actos has been sold since 1999 and its side effects are still being studied.

 In 2012 a large cohort study of Actos was done.  This Actos study showed that Actos was associated with an increased rate of bladder cancer. The rate of bladder cancer from Actos increased the longer patients took Actos.  The highest rate of bladder cancer was seen in patients that had taken Actos for more than two (2) years. For patients in Pittsburgh that have taken or are taking Actos, the conclusion of the study is that Actos is associated with an increased risk of bladder cancer among people with type 2 diabetes.

Though the Actos lawsuit settlement has not been finalized it could happen any time.  Anyone in Pittsburgh with Type II diabetes who as been diagnosed with bladder cancer after taking Actos are encouraged to contact a lawyer to file their claims as soon as possible.

----- Share this post :
Share on Facebook
Share on Twitter
Share on StumbleUpon
Share on Delicious
Share on Reddit
Share on Digg
Share on simpy
Share on Technorati
furl Share on furl
Feeds RSS Subscribe to Feeds RSS

No comments:

Post a Comment